ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years
Camille Blériot
Matched on ORCID iD 0000-0002-4298-2888; OpenAlex author ID A5037504237. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 3
- Resident tissue macrophages transfer selenium transporter protein to protect pancreatic cancer from ferroptosis. Co-author DOI 10.1016/j.cell.2026.09.001↗
- Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.ctarc.2025.100939↗
- Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC. Co-author DOI 10.1007/s13346-023-01479-5↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Florent Ginhoux · 3 shared papers, 2024–2026 · strength 0.61
- Paper Multicellular tumor spheroid model to study the multifaceted role of tumor-associated macrophages in PDAC. DOI 10.1007/s13346-023-01479-5↗
- Paper Resident tissue macrophages transfer selenium transporter protein to protect pancreatic cancer from ferroptosis. DOI 10.1016/j.cell.2026.09.001↗
- Paper Molecular analysis highlights TREM2 as a discriminating biomarker for patients suffering from pancreatic ductal adenoca… DOI 10.1016/j.ctarc.2025.100939↗
- Nadège Bidan · 1 shared paper, 2024 · strength 0.21
- Simona Mura · 1 shared paper, 2024 · strength 0.21
- Li Jiang · 1 shared paper, 2026 · strength 0.20
- Wei Guo · 1 shared paper, 2026 · strength 0.20
- Shulin Zhao · 1 shared paper, 2026 · strength 0.20
- Pengyi Liu · 1 shared paper, 2026 · strength 0.20
- Dimitrios Papakonstantinou · 1 shared paper, 2025 · strength 0.20
- Antoine Hollebecque · 1 shared paper, 2025 · strength 0.20
- Alice Boilève · 1 shared paper, 2025 · strength 0.20
- Michel Pierre Ducreux · 1 shared paper, 2025 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.